26th Apr 2017 07:00
Press release | April 26, 2017 |
Verseon Corporation
("Verseon" or the "Company")
Result of 2017 Annual General Meeting
FREMONT, Calif.-Verseon Corporation (AIM:VSN), a technology-based pharmaceutical company, confirms that all resolutions put to shareholders at the Company's Annual General Meeting held on April 25, 2017 at 14:00 PDT (22:00 BST) were duly passed.
- Ends -
For further information, please contact
Verseon Corporation | www.verseon.com |
Tina Schlafly | +1 (510) 225 9000 |
Cenkos Securities (NOMAD and Joint Broker) | |
Neil McDonald / Beth McKiernan | +44 (0) 20 7397 8900 |
Cantor Fitzgerald Europe (Joint Broker) | |
Marc Milmo / Phil Davies / Callum Butterfield | +44 (0) 20 7894 7000 |
Mirabaud Securities LLP (Joint Broker) | |
Peter Krens | +44 (0) 20 7321 2508 |
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers) | |
Henry Harrison-Topham / Jamie Hooper | +44 (0) 20 7466 5000 |
For trade and pharma media enquiries, please contact
Vane Percy & Roberts | |
Simon Vane Percy | +44 (0) 1737 821 890 |
Related Shares:
VERS.L